Cepheid
Luben Li is an experienced leader in strategic planning and business development, currently serving as Vice President of Strategy and Business Development at Cepheid since May 2021, having previously held the role of Senior Director of Global Strategy. Prior to this, Luben worked at Boston Consulting Group as a Principal, specializing in management consulting within the healthcare sector from June 2012 to September 2021. Luben holds a Bachelor of Applied Science in Bioengineering from the University of Pennsylvania and a Bachelor of Science in Economics with a focus on Finance and Management from The Wharton School.
This person is not in any offices
Cepheid
9 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.